The 2021 ESC guideline on cardiovascular disease (CVD) prevention categorizes moderate and severe chronic kidney disease (CKD) as high and very-high CVD risk status regardless of other factors like age and does not include estimated glomerular filtration rate (eGFR) and albuminuria in its algorithms, SCORE2 and SCORE2-OP, to predict CVD risk. We developed and validated an "Add-on" to incorporate CKD measures into these algorithms, using a validated approach.

Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP / Matsushita, K., Kaptoge, S., Hageman, S.H., Sang, Y., Ballew, S.H., Grams, M.E., Surapaneni, A., Sun, L., Arnlov, J., Bozic, M., Brenner, H., Brunskill, N.J., Chang, A.R., Chinnadurai, R., Cirillo, M., Correa, A., Ebert, N., Eckardt, K.U., Gansevoort, R.T., Gutierrez, O., et al.. - In: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. - ISSN 2047-4873. - 30:1(2023), pp. 8-16. [10.1093/eurjpc/zwac176]

Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP

Cirillo, Massimo;
2023

Abstract

The 2021 ESC guideline on cardiovascular disease (CVD) prevention categorizes moderate and severe chronic kidney disease (CKD) as high and very-high CVD risk status regardless of other factors like age and does not include estimated glomerular filtration rate (eGFR) and albuminuria in its algorithms, SCORE2 and SCORE2-OP, to predict CVD risk. We developed and validated an "Add-on" to incorporate CKD measures into these algorithms, using a validated approach.
2023
Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP / Matsushita, K., Kaptoge, S., Hageman, S.H., Sang, Y., Ballew, S.H., Grams, M.E., Surapaneni, A., Sun, L., Arnlov, J., Bozic, M., Brenner, H., Brunskill, N.J., Chang, A.R., Chinnadurai, R., Cirillo, M., Correa, A., Ebert, N., Eckardt, K.U., Gansevoort, R.T., Gutierrez, O., et al.. - In: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. - ISSN 2047-4873. - 30:1(2023), pp. 8-16. [10.1093/eurjpc/zwac176]
File in questo prodotto:
File Dimensione Formato  
2022 CKD-PC EurJPrevCard cvd prediction, proof.pdf

solo utenti autorizzati

Descrizione: bozze
Tipologia: Documento in Pre-print
Licenza: Accesso privato/ristretto
Dimensione 1.17 MB
Formato Adobe PDF
1.17 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/958393
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 81
  • ???jsp.display-item.citation.isi??? 52
social impact